MwanzoORCHPHARMA • NSE
add
Orchid Pharma Ltd
Bei iliyotangulia
₹ 705.80
Bei za siku
₹ 705.55 - ₹ 718.55
Bei za mwaka
₹ 603.80 - ₹ 1,997.40
Thamani ya kampuni katika soko
35.79B INR
Wastani wa hisa zilizouzwa
elfu 63.25
Uwiano wa bei na mapato
41.98
Mgao wa faida
-
Ubadilishanaji wa msingi
NSE
Habari za soko
Fedha
Taarifa ya Mapato
Mapato
Mapato halisi
| (INR) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato | 1.73B | -29.25% |
Matumizi ya uendeshaji wa biashara | 685.42M | -2.23% |
Mapato halisi | 149.11M | -49.20% |
Kiwango cha faida halisi | 8.62 | -28.23% |
Mapato kwa kila hisa | — | — |
EBITDA | 141.58M | -55.75% |
Asilimia ya kodi ya mapato | — | — |
Taarifa ya Hali ya Kifedha
Jumla ya mali
Jumla ya dhima
| (INR) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Uwekezaji wa pesa taslimu na vipindi vifupi | 1.80B | 4,871.20% |
Jumla ya mali | — | — |
Jumla ya dhima | — | — |
Jumla ya hisa | 12.67B | — |
hisa zilizosalia | 50.72M | — |
Uwiano wa bei na thamani | 2.82 | — |
Faida inayotokana na mali | — | — |
Faida inayotokana mtaji | 0.96% | — |
Mtiririko wa pesa
Mabadiliko halisi ya pesa taslimu
| (INR) | Jun 2025info | Mabadiliko Tangu Mwaka Uliopita |
|---|---|---|
Mapato halisi | 149.11M | -49.20% |
Pesa kutokana na shughuli | — | — |
Pesa kutokana na uwekezaji | — | — |
Pesa kutokana na ufadhili | — | — |
Mabadiliko halisi ya pesa taslimu | — | — |
Mtiririko huru wa pesa | — | — |
Kuhusu
Orchid Pharma Limited is an Indian pharmaceutical company based in Chennai, founded on 1 July 1992. As of 2024, it was among the top fortune 500 Indian companies by market capitalization. Orchid Pharma is the only pharma company in India to have discovered a New Drug Enmetazobactam which is now approved in United States, Europe and India. Wikipedia
Ilianzishwa
1992
Tovuti
Wafanyakazi
736
